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Response to: ‘IL-23 expression and activation
of autophagy in synovium and PBMCs of
HLA-B27 positive patients with ankylosing
spondylitis‘ by Neerinckx et al.
We read with interest the study by Neerinckx et al1 addressing
the expression of interleukin (IL)-23p19 and of autophagy
genes in the synovium and in the peripheral blood mononuclear
cells of patients with ankylosing spondylitis (AS). Differently
from our observation in the gut,2 the authors failed to demon-
strate any signiﬁcant increase by RT-PCR in the expression
of synovium autophagy-related genes (ATG16L1, IRGM,
MAP1LC3A, ATG5, HSPA8 and HSP90AA1) together with no
signiﬁcant overexpression of IL-23p19 compared with disease
and healthy controls.
We have previously demonstrated by immunohistochemistry
that in the gut of AS, Paneth cells (PC), specialised epithelial
cells located at the bottom of intestinal crypts, highly express
IL-23p19.3 Subsequent studies have demonstrated the role of
the autophagy related ATG16L1 gene, a genetic risk factor for
Crohn’s disease, in causing PC dysfunction4 and the important
interconnection between PC and autophagy in determining the
pathogenesis of murine Crohn’s disease.5 Starting from these
ﬁndings, we studied the expression of autophagy in the gut
of patients with AS. We demonstrated a signiﬁcant upregulation
of the genes involved in the autophagy pathway in the gut of
patients with AS by RT-PCR and conﬁrmed autophagy activa-
tion in inﬁltrating mononuclear cells and epithelial cells resem-
bling PCs.2 Interestingly, modulation of autophagy results in
a signiﬁcant modulation of the expression of IL-23p19 in
isolated lamina propria mononuclear cells of patients and con-
trols.2 6 Autophagy has been demonstrated to play an important
role in the innate immune response against intestinal bacteria
and its expression seems to be potentially modulated by speciﬁc
gut microbiota.7–9 The presence of an active bacterial stimula-
tion of the innate immune system in patients with AS is indir-
ectly suggested by the activation of PC in producing their
antimicrobial products (lysozyme, phospholipase A2 and defen-
sin 5).10 In this scenario, the activation of autophagy genes in
the gut of patients with AS and its absence in the synovial
samples and in the peripheral blood of patients with AS, is not
surprising in our opinion.
Conversely, the absence of any signiﬁcant increase of
IL-23p19 expression in the synovial samples of patients with AS
observed by Neerinckx et al appears to be surprising.1 IL-23p19
has been, in fact, demonstrated by immunohistochemistry to be
overexpressed in the inﬂamed tissues of patients with AS (gut
and zygapophysial joints).3 11 Since RT-PCR results need to be
conﬁrmed by protein demonstration, immunohistochemistry
should also be performed in order to conﬁrm this interesting
observation. We, however, agree with Neerinckx et al1 in think-
ing that IL-23p19 might play a tissue-speciﬁc role (in the gut
and/or in the lymph node), speciﬁcally priming the subset of
IL-23-responsive proinﬂammatory cells.
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